Elekta completes $75M purchase of CMS
Elekta adds to radiation therapy line with CMS acquisition. Source: University of Iowa  
Elekta has completed its previously announced acquisition of CMS for $75 million in cash.

CMS develops and sells radiation therapy planning solutions, supporting more than 1,500 sites in clinical operation.

The acquisition will add to Elekta's strategy in radiation therapy planning and management of images and information, accelerate the development of cancer treatment solutions and bring these tools to market, the Stockholm, Sweden-based Elekta said.

From a financial reporting perspective, CMS will be consolidated into Elekta’s accounts as of March 4.